Physician

Jeffrey S Arkles, MD

According to 2025 Medicare claims, Jeffrey Arkles, MD (NPI: 1841405222) practices cardiac electrophysiology in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is THE HEART GROUP OF LANCASTER GENERAL HEALTH (NPI: 1760793210; TIN: 300634510) and primary practice location at 17603-2962. Arkles is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019) and Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Arkles' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,406 traditional Medicare patients, billed 5,088 HCPCS/CPT codes, and received $276,521 in Medicare payments. The top billing code was 93280 (Programming of dual lead pacemaker system). Part D data shows 844 prescription claims across 255 beneficiaries totaling $198,180 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 38 records totaling $3,274. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $63,763 to $276,521. Similarly, Part D prescription costs have risen steadily, from $19,747 to $198,180. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	175	446	$63,763
2016	209	583	$71,594
2017	1,158	1,933	$93,881
2018	1,425	2,562	$135,107
2019	1,595	2,961	$129,845
2020	1,244	2,405	$121,266
2021	1,674	3,225	$139,011
2022	1,986	3,522	$139,591
2023	2,321	5,019	$263,789
2024	2,406	5,088	$276,521

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	57	227	$19,747
2016	54	264	$27,110
2017	40	156	$10,876
2018	20	59	$8,171
2019	33	85	$8,678
2020	37	93	$19,513
2021	25	52	$7,874
2022	52	104	$28,283
2023	223	795	$139,887
2024	255	844	$198,180

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93280	Programming of dual lead pacemaker system	315	325	$46
93298	Evaluation of cardiac rhythm monitor system, remote up to 30 days	231	529	$43
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	744	918	$19
93244	Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days	284	291	$16
93296	Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days	948	1,152	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	131	6,775	$128,684
Xarelto	Rivaroxaban	30	1,920	$35,251
Multaq	Dronedarone Hcl	18	840	$22,224
Flecainide Acetate	Flecainide Acetate	73	3,662	$3,013
Metoprolol Succinate	Metoprolol Succinate	176	11,585	$2,660

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$3,274	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey S. Arkles, MD?

Tedicare shows public-source Medicare data for Jeffrey S. Arkles, MD (NPI 1841405222), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey S. Arkles, MD have ACO affiliation data?

Jeffrey S. Arkles, MD is shown with ACO affiliation data for Lancaster General Health Community Care Collaborative, LLC (MSSP, ACO ID A2019) and Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to Jeffrey S. Arkles, MD?

Jeffrey S. Arkles, MD is linked to THE HEART GROUP OF LANCASTER GENERAL HEALTH (billing NPI 1760793210) in the available physician profile data.

Does Jeffrey S. Arkles, MD have Open Payments data?

Jeffrey S. Arkles, MD has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.